DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

Outcome of Ischemic Stroke at Six Months with Neuroglobin as a Marker

by Yetty Ramli, MD, SpN(K); Fadhlan Rusdi, MD, SpN; Mohammad Kurniawan, MD, SpN(K); Mohamad Sadikin, MD, DSc; and Florencia Evelyn, MD Drs. Ramli, Rusdi, Kurniawan, and Evelyn are with the

Analysis of Levels of Vitamin D, Beta-Amyloid 42, Indoxyl Sulfate, and Serum Parathyroid Hormone in Hemodialysis Patients with Cognitive Impairment

by Prof. Yuliarni Syafrita, Sp.N(K); Harnavi Harun, Sp.PD-KGH, FINASIM; Restu Susanti, Sp.S(K) M. Biomed; and Syarif Indra, Sp.N(K) Prof. Syafrita and Drs. Susanti Indra are with the Department of Neurology,

Risk Management: Artificial Intelligence in Clinical Practice

by Donna Vanderpool, MBA, JD Ms. Vanderpool is Director of Risk Management at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures:

CNS Summit 2024 Abstracts of Poster Presentations

A Message from the Editor Dear Colleagues: Welcome to the annual CNS Summit Abstracts of Poster Presentations supplement to Innovations in Clinical Neuroscience. We are pleased to provide you with

Letter to the Editor: Activation of the Serotonergic Neurotransmission is a Double-edged Sword in the Treatment of Burning Mouth Syndrome

Innov Clin Neurosci. 2024;21(7–9):8–9. Dear Editor: In the treatment of chronic pain of unknown cause, contradictions can arise; a drug for the treatment of a disease might be a cause